Have a feature idea you'd love to see implemented?
Let us know!
NNVC Nanoviricides Inc
Price (delayed)
$1.49
Market cap
$21.87M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.7
Enterprise value
$17.07M
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide® class of drug candidates are designed to specifically attack enveloped
Highlights
The EPS has grown by 15% from the previous quarter and by 5% YoY
NNVC's net income is up by 13% QoQ and by 3.4% YoY
The equity has declined by 23% year-on-year but it has grown by 8% since the previous quarter
NNVC's quick ratio has dropped by 77% year-on-year and by 12% since the previous quarter
Key stats
What are the main financial stats of NNVC
Market
Valuations
Earnings
Shares outstanding
14.68M
Market cap
$21.87M
Enterprise value
$17.07M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.54
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$8.24M
EBITDA
-$7.49M
Free cash flow
-$6.47M
Per share
Balance sheet
Liquidity
EPS
-$0.7
Free cash flow per share
-$0.55
Book value per share
$0.97
Revenue per share
$0
TBVPS
$1.05
Total assets
$12.82M
Total liabilities
$1.36M
Debt
$0
Equity
$11.46M
Working capital
$3.61M
Debt to equity
0
Current ratio
3.66
Quick ratio
3.53
Net debt/EBITDA
0.64
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-62.5%
Return on equity
-69.8%
Return on invested capital
-114.1%
Return on capital employed
-71.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NNVC stock price
How has the Nanoviricides stock price performed over time
Intraday
0.68%
1 week
0%
1 month
2.76%
1 year
28.45%
YTD
46.08%
QTD
-0.67%
Financial performance
How have Nanoviricides's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.52M
Net income
-$8.29M
Gross margin
N/A
Net margin
N/A
Nanoviricides's operating income has increased by 13% QoQ and by 4.8% YoY
NNVC's net income is up by 13% QoQ and by 3.4% YoY
Growth
What is Nanoviricides's growth rate over time
Valuation
What is Nanoviricides stock price valuation
P/E
N/A
P/B
1.54
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 15% from the previous quarter and by 5% YoY
The equity has declined by 23% year-on-year but it has grown by 8% since the previous quarter
The stock's price to book (P/B) is 18% more than its last 4 quarters average of 1.3 and 10% more than its 5-year quarterly average of 1.4
Efficiency
How efficient is Nanoviricides business performance
Nanoviricides's return on equity has shrunk by 51% YoY but it has increased by 7% QoQ
NNVC's return on assets is down by 42% year-on-year but it is up by 6% since the previous quarter
Nanoviricides's return on invested capital has increased by 8% QoQ but it has decreased by 8% YoY
Dividends
What is NNVC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NNVC.
Financial health
How did Nanoviricides financials performed over time
NNVC's quick ratio has dropped by 77% year-on-year and by 12% since the previous quarter
The current ratio has shrunk by 77% YoY and by 15% QoQ
NNVC's debt is 100% lower than its equity
The equity has declined by 23% year-on-year but it has grown by 8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.